Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of SK-1405 in patients undergoing hemodialysis
jRCT2080223782Phase 1Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of SK-1405 in chronic kidney disease (CKD), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoint: Primary pharmacokinetic endpoints. Started Jan 2018; status: completed.
02
Drugs
SK-1405
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080223782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223782.